Lucchese Joseph 4
4 · Timber Pharmaceuticals, Inc. · Filed Apr 18, 2023
Insider Transaction Report
Form 4
Lucchese Joseph
Executive VP & CFO
Transactions
- Award
Stock Option (right to buy)
2023-04-15+22,505→ 22,505 totalExercise: $1.66Exp: 2032-04-14→ Common Stock (22,505 underlying)
Footnotes (1)
- [F1]25% of the options vest on April 15, 2024, and the remaining shares will become exercisable in 36 equal monthly installments beginning on May 15, 2024, as long as the Reporting Person remains in continuous service with Timber Pharmaceuticals, Inc. through each vesting date.